Aprea Therapeutics (APRE) Q2 2026 Earnings

May 13Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.71
-0.55
-0.38
-0.21

Details

Expected EPS
-0.2125
Actual EPS
-0.22
Surprise EPS
-0.01
Surprise Percent
-3.53%

Description

⁨Aprea Therapeutics⁩ (⁦APRE⁩) has reported earnings of ⁦-0.22⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts